Literature DB >> 25894681

Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets.

Kjell Fuxe1, Luigi F Agnati2, Manuela Marcoli3,4, Dasiel O Borroto-Escuela5.   

Abstract

Already in the 1960s the architecture and pharmacology of the brainstem dopamine (DA) and noradrenaline (NA) neurons with formation of vast numbers of DA and NA terminal plexa of the central nervous system (CNS) indicated that they may not only communicate via synaptic transmission. In the 1980s the theory of volume transmission (VT) was introduced as a major communication together with synaptic transmission in the CNS. VT is an extracellular and cerebrospinal fluid transmission of chemical signals like transmitters, modulators etc. moving along energy gradients making diffusion and flow of VT signals possible. VT interacts with synaptic transmission mainly through direct receptor-receptor interactions in synaptic and extrasynaptic heteroreceptor complexes and their signaling cascades. The DA and NA neurons are specialized for extrasynaptic VT at the soma-dendrtitic and terminal level. The catecholamines released target multiple DA and adrenergic subtypes on nerve cells, astroglia and microglia which are the major cell components of the trophic units building up the neural-glial networks of the CNS. DA and NA VT can modulate not only the strength of synaptic transmission but also the VT signaling of the astroglia and microglia of high relevance for neuron-glia interactions. The catecholamine VT targeting astroglia can modulate the fundamental functions of astroglia observed in neuroenergetics, in the Glymphatic system, in the central renin-angiotensin system and in the production of long-distance calcium waves. Also the astrocytic and microglial DA and adrenergic receptor subtypes mediating DA and NA VT can be significant drug targets in neurological and psychiatric disease.

Entities:  

Keywords:  Adrenergic receptors; Astroglia; Catecholamine neurons; Dopamine receptors; Neuron–glia interactions; Volume transmission

Mesh:

Substances:

Year:  2015        PMID: 25894681     DOI: 10.1007/s11064-015-1574-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  135 in total

Review 1.  Central nicotinic receptors, neurotrophic factors and neuroprotection.

Authors:  N Belluardo; G Mudò; M Blum; K Fuxe
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

Review 2.  Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease.

Authors:  K Fuxe; L F Agnati; K Jacobsen; J Hillion; M Canals; M Torvinen; B Tinner-Staines; W Staines; D Rosin; A Terasmaa; P Popoli; G Leo; V Vergoni; C Lluis; F Ciruela; R Franco; S Ferré
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

Review 3.  Astrocyte control of synaptic transmission and neurovascular coupling.

Authors:  Philip G Haydon; Giorgio Carmignoto
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

Review 4.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

5.  Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy.

Authors:  Grant R J Gordon; Dinara V Baimoukhametova; Sarah A Hewitt; W R A Kosala J S Rajapaksha; Thomas E Fisher; Jaideep S Bains
Journal:  Nat Neurosci       Date:  2005-07-03       Impact factor: 24.884

6.  Evidence for the existence of angiotensinogen mRNA in magnocellular paraventricular hypothalamic neurons.

Authors:  M Aronsson; K Almasan; K Fuxe; A Cintra; A Härfstrand; J A Gustafsson; D Ganten
Journal:  Acta Physiol Scand       Date:  1988-04

7.  Effect of large mesencephalic-diencephalic lesions on the noradrenalin, dopamine and 5-hydroxytryptamine neurons of the central nervous system.

Authors:  N E Andén; K Fuxe; K Larsson
Journal:  Experientia       Date:  1966-12-15

8.  The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes.

Authors:  Kiyoe Ohta; Sadako Kuno; Seiji Inoue; Erika Ikeda; Aya Fujinami; Mitsuhiro Ohta
Journal:  J Neurol Sci       Date:  2010-02-02       Impact factor: 3.181

9.  Rat prolactin and hypothalamic catecholamine nerve terminal systems. Evidence for rapid and discrete increases in dopamine and noradrenaline turnover in the hypophysectomized male rat.

Authors:  K Andersson; K Fuxe; P Eneroth; F Nyberg; P Roos
Journal:  Eur J Pharmacol       Date:  1981-12-03       Impact factor: 4.432

10.  Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra.

Authors:  Pablo Garrido-Gil; Rita Valenzuela; Begoña Villar-Cheda; Jose L Lanciego; Jose L Labandeira-Garcia
Journal:  Brain Struct Funct       Date:  2012-03-11       Impact factor: 3.270

View more
  33 in total

1.  Astrocytes, Metabolism, Signaling and Brain Drains: Introduction to the Special Issue in Honor of Gerald Dienel.

Authors:  Caroline Rae; Ursula Sonnewald
Journal:  Neurochem Res       Date:  2015-12       Impact factor: 3.996

Review 2.  Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

Authors:  Saranya Sundaram; Rachel L Hughes; Eric Peterson; Eva M Müller-Oehring; Helen M Brontë-Stewart; Kathleen L Poston; Afik Faerman; Chloe Bhowmick; Tilman Schulte
Journal:  Neurosci Biobehav Rev       Date:  2019-05-24       Impact factor: 8.989

3.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

4.  The triplet puzzle theory indicates extensive formation of heteromers between opioid and chemokine receptor subtypes.

Authors:  Alexander O Tarakanov; Kjell Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2015-07-02       Impact factor: 3.575

5.  The Wiring Logic of an Identified Serotonergic Neuron That Spans Sensory Networks.

Authors:  Kaylynn E Coates; Steven A Calle-Schuler; Levi M Helmick; Victoria L Knotts; Brennah N Martik; Farzaan Salman; Lauren T Warner; Sophia V Valla; Davi D Bock; Andrew M Dacks
Journal:  J Neurosci       Date:  2020-07-08       Impact factor: 6.167

6.  Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway.

Authors:  E A Nickoloff-Bybel; P Mackie; K Runner; S M Matt; H Khoshbouei; P J Gaskill
Journal:  Brain Behav Immun       Date:  2019-08-27       Impact factor: 7.217

7.  Serotonergic modulation across sensory modalities.

Authors:  Tyler R Sizemore; Laura M Hurley; Andrew M Dacks
Journal:  J Neurophysiol       Date:  2020-05-13       Impact factor: 2.714

8.  Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes.

Authors:  Chiara Cervetto; Arianna Venturini; Diego Guidolin; Guido Maura; Mario Passalacqua; Carlo Tacchetti; Pietro Cortelli; Susanna Genedani; Simona Candiani; Paola Ramoino; Simone Pelassa; Manuela Marcoli; Luigi F Agnati
Journal:  J Mol Neurosci       Date:  2018-07-20       Impact factor: 3.444

Review 9.  Locus Coeruleus Modulates Neuroinflammation in Parkinsonism and Dementia.

Authors:  Filippo Sean Giorgi; Francesca Biagioni; Alessandro Galgani; Nicola Pavese; Gloria Lazzeri; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

10.  Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals.

Authors:  Chun-Hsien Chu; Shijun Wang; Chia-Ling Li; Shih-Heng Chen; Chih-Fen Hu; Yi-Lun Chung; Shiou-Lan Chen; Qingshan Wang; Ru-Band Lu; Hui-Ming Gao; Jau-Shyong Hong
Journal:  Brain Behav Immun       Date:  2016-04-27       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.